Vegf peptides and their use for inhibiting angiogenesis

Details for Australian Patent Application No. 2002210713 (hide)

Owner Ark Therapeutics Ltd.

Inventors Lohr, Marianne; Jia, Haiyan; Zachary, Ian; Selwood, David; Davis, Dana

Agent Blake Dawson Waldron

Pub. Number AU-B-2002210713

PCT Pub. Number WO02/34767

Priority 0026134 25.10.00 GB

Filing date 25 October 2001

Wipo publication date 6 May 2002

Acceptance publication date 3 March 2005

International Classifications

C07K 007/06 Peptides having 5 to 20 amino acids in a fully defined sequence

A61K 038/10 Medicinal preparations containing peptides - Peptides having 12 to 20 amino acids

A61K 038/08 Medicinal preparations containing peptides - Peptides having 5 to 11 amino acids

C07K 014/52 Peptides having more than 20 amino acids

C07K 007/08 Peptides having 5 to 20 amino acids in a fully defined sequence

Event Publications

3 March 2005 Application Accepted

  Published as AU-B-2002210713

30 June 2005 Standard Patent Sealed

20 May 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002210714

2002210712-Telephone call management